Comparative Effects of Platelet-Rich Plasma, Platelet Lysate, and Fetal Calf Serum on Mesenchymal Stem Cells
- Autores: Lykov A.1,2, Bondarenko N.1,2, Surovtseva M.1,2, Kim I.1,2, Poveshchenko O.1,2, Pokushalov E.1,2, Konenkov V.1
-
Afiliações:
- Research Institute of Clinical and Experimental Lymphology
- E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
- Edição: Volume 163, Nº 6 (2017)
- Páginas: 757-760
- Seção: Immunology and Microbiology
- URL: https://journals.rcsi.science/0007-4888/article/view/239238
- DOI: https://doi.org/10.1007/s10517-017-3897-5
- ID: 239238
Citar
Resumo
We studied the effects of human platelet-rich plasma and platelet lysate on proliferation, migration, and colony-forming properties of rat mesenchymal stem cells. Platelet-rich plasma and platelet lysate stimulated the proliferation, migration, and colony formation of mesenchymal stem cells. A real-time study showed that platelet-rich plasma produces the most potent stimulatory effect, while both platelet-rich plasma and platelet lysate stimulated migration of cells.
Sobre autores
A. Lykov
Research Institute of Clinical and Experimental Lymphology; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Autor responsável pela correspondência
Email: aplykov2@mail.ru
Rússia, Novosibirsk; Novosibirsk
N. Bondarenko
Research Institute of Clinical and Experimental Lymphology; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: aplykov2@mail.ru
Rússia, Novosibirsk; Novosibirsk
M. Surovtseva
Research Institute of Clinical and Experimental Lymphology; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: aplykov2@mail.ru
Rússia, Novosibirsk; Novosibirsk
I. Kim
Research Institute of Clinical and Experimental Lymphology; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: aplykov2@mail.ru
Rússia, Novosibirsk; Novosibirsk
O. Poveshchenko
Research Institute of Clinical and Experimental Lymphology; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: aplykov2@mail.ru
Rússia, Novosibirsk; Novosibirsk
E. Pokushalov
Research Institute of Clinical and Experimental Lymphology; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: aplykov2@mail.ru
Rússia, Novosibirsk; Novosibirsk
V. Konenkov
Research Institute of Clinical and Experimental Lymphology
Email: aplykov2@mail.ru
Rússia, Novosibirsk